Edition:
United Kingdom

People: Cutera Inc (CUTR.OQ)

CUTR.OQ on NASDAQ Stock Exchange Global Select Market

40.75USD
21 May 2018
Change (% chg)

$-0.40 (-0.97%)
Prev Close
$41.15
Open
$41.20
Day's High
$41.45
Day's Low
$40.60
Volume
43,430
Avg. Vol
59,351
52-wk High
$56.05
52-wk Low
$20.25

Reinstein, James 

Mr. James A. Reinstein serves as President, Chief Executive Officer, Director of the Company. Prior to joining Cutera, Mr. Reinstein served as the CEO of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Prior to Drawbridge, He was the CEO of Aptus Endosystems from 2012 until its acquisition by Medtronic in 2015. From 2007-2012, he was the EVP and Chief Commercial Officer of Cyberonics, Inc. At Cyberonics, Mr. Reinstein drove the strategy for many of its departments including Research & Development, Clinical Research, and New Business Development and led a global commercial team of over 200 employees, growing revenues by 250% within three years. Prior to Cyberonics, Mr. Reinstein held a variety of management positions of increasing responsibility within Boston Scientific Corporation from 1990-2007, including Vice President and Regional Head of an Asian business unit; Country Director of Boston Scientific de Mexico; and European Head for its Neurovascular Division. He began his career with Proctor & Gamble.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --